Delivery Order SPE2DB20D3103-SPE2DB25FP8F3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for LENVIMA 14 mg daily dose (60-count supply) on August 14, 2025, with an ultimate completion date of September 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. LENVIMA is a targeted cancer therapy medication, and this procurement supports...
- The Defense Logistics Agency awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for LENVIMA 10 mg daily dose 30-count supply on July 29, 2025, with completion scheduled for August 19, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. LENVIMA (lenvatinib) is a targeted cancer therapy used to treat various malignancies,...
- The Defense Logistics Agency (DLA) awarded a $10,223.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 20 MG daily dose (60-count supply) with an ultimate completion date of August 19, 2025. This non-set-aside competitive award was issued on July 29, 2025, with performance to be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. LENVIMA is a targeted cancer therapy medication, reflecting the federal government's continued reliance on...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for LENVIMA 10 MG daily dose tablets (30-count supply). This firm fixed-price, non-set-aside contract was awarded on August 18, 2025, with an ultimate completion date of September 9, 2025. LENVIMA (lenvatinib) is a targeted cancer therapy used to treat various malignancies, reflecting the pharmaceutical distributor's role in supplying specialized oncology medications to federal...
- The Defense Logistics Agency awarded a $10,223.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 10 mg daily dose tablets (30-count package) with an ultimate completion date of August 19, 2025. This non-competitive delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. LENVIMA is a targeted cancer therapy indicated for multiple malignancies, and this award reflects...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for LENVIMA 8 mg daily dose in a quantity of 60 units, with a ceiling value of $10,223.24. This firm fixed-price delivery order, issued on August 11, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of LENVIMA 10 mg daily dose in a 30-count package with a ceiling value of $10,223.24. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 25, 2025, and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $9,910.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Lenvima 14 mg daily dose in a 60-count quantity. This non-set-aside contract was awarded on May 6, 2025, with an ultimate completion date of May 28, 2025. The order will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Lenvima is a targeted cancer therapy used in the treatment of various malignancies, reflecting the Defense Logistics...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order valued at $9,910.95 by the Defense Logistics Agency on May 30, 2025, for the supply of LENVIMA 8 mg daily dose (60-count supply). The contract carries a firm fixed price structure with an ultimate completion date of June 23, 2025, and was issued under a non-set-aside competitive procurement. This delivery order represents a child contract issued against AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for LENVIMA 18 mg daily dose tablets (90-count supply) valued at $10,223.24 under a firm fixed-price contract type. The award was made on August 8, 2025, with an ultimate completion date of August 29, 2025, and no set-aside designation was utilized. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical delivery. This delivery order...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP8F3Delivery Order
The Defense Logistics Agency awarded a $10,223.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 8 mg daily dose (60-count supply) with an ultimate completion date of September 2, 2025. This non-set-aside contract was competitively awarded on August 11, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. LENVIMA (lenvatinib) is a targeted cancer therapy used in the treatment of various malignancies, reflecting the Defense Logistics Agency's procurement of specialized pharmaceutical products for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract vehicle SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medical products and medications to support Defense Health Agency operations and other government healthcare programs. The delivery order structure allows for flexible fulfillment of specific pharmaceutical needs within the broader framework of the company's global pharmaceutical support agreement with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 8/11/25 |